Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab endoscopy trial for mucosal healing in Crohn's disease involving the colon
2005-005291-32Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- May 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Crohn's disease comparing Adalimumab with Placebo (2 arms). Primary endpoint: Absence of mucosal ulceration on endoscopy at Week 12. Started May 2006; status: completed.
02
Drugs
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2005-005291-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005291-32.